AB-PINACA-d9 (exempt preparation) (Item No. 22859) is intended for use as an internal standard for the quantification of AB-PINACA (Item Nos. 14038 | ISO60210) by GC- or LC-MS. AB-PINACA is categorized as a cannabinoid.1 AB-PINACA is regulated as a Schedule I compound in the United States. AB-PINACA-d9 (exempt preparation) (Item No. 22859) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
Description
AB-PINACA-d9 (Item No. 15057) is intended for use as an internal standard for the quantification of AB-PINACA (Item Nos. 14038 | ISO60210) by GC- or LC-MS. AB-PINACA is categorized as a cannabinoid.1 AB-PINACA-d9 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
References
[1] N. UCHIYAMA. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products[J]. Forensic Toxicology, 2012, 31 1: 93-100. DOI: 10.1007/s11419-012-0171-4
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
